Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

Cited by (646)

Items 301–400 of 646

1. Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes
   Rodrigo Barbachan Mansur, Gabriel R. Fries, Mehala Subramaniapillai, Sophia Frangou, Fernanda G. De Felice, Natalie Rasgon, Bruce S. McEwen, Elisa Macedo Brietzke, Roger S. McIntyre · 2018 · Journal of Psychiatric Research
2. Neural correlates of visual aesthetic appreciation: insights from non-invasive brain stimulation
   Zaira Cattaneo · 2019 · Experimental Brain Research
3. Electrical stimulation of the hippocampus disrupts prepulse inhibition in rats: frequency- and site-dependent effects.
   J. Howland, Erin M Mackenzie, Tonia T. Yim, P. Taepavarapruk, A. Phillips · 2004 · Behavioural Brain Research
4. Microvessel length density, total length, and length per neuron in five subcortical regions in schizophrenia
   Paweł Kreczmański, Helmut Heinsen, Valentina Mantua, Fritz Woltersdorf, Thorsten Masson, Norbert Ulfig, Rainald Schmidt‐Kastner, Hubert Korr, Harry W.M. Steinbusch, Patrick R. Hof et al. · 2009 · Acta Neuropathologica
5. Schizophrenia proteomics: biomarkers on the path to laboratory medicine?
   Shaheen Emmanuel Lakhan · 2006 · Diagnostic Pathology
6. Roles for the TGFβ Superfamily in the Development and Survival of Midbrain Dopaminergic Neurons
   Shane Vincent Hegarty, Aideen M. Sullivan, Gerard W. O’Keeffe · 2014 · Molecular Neurobiology
7. The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult life
   Seán Froudist‐Walsh, Michael Bloomfield, Mattia Veronese, Jasmin Kroll, Vyacheslav R. Karolis, Sameer Jauhar, Ilaria Bonoldi, Philip K. McGuire, Shitij Kapur, Robin M. Murray et al. · 2017 · eLife
8. Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response
   Hugo Geerts, Äthan Spiros, Patrick Roberts, Roy E. Twyman, Larry D Alphs, Anthony A. Grace · 2012 · PLoS ONE
9. Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats
   Marco Bortolato, Valentina Bini, Roberto Frau, Paola Devoto, Alessandra Pardu, Yijun Fan, Marylou V. Solbrig · 2014 · European Neuropsychopharmacology
10. Discovery and development of integrative biological markers for schizophrenia
    Viola Oertel‐Knöchel, Robert A. Bittner, Christian Knöchel, David Prvulovic, Harald Juergen Hampel · 2011 · Progress in Neurobiology
11. Corticostriatal stimulation compensates for medial frontal inactivation during interval timing
    Eric B. Emmons, Morgan Kennedy, Young-Cho Kim, Nandakumar S. Narayanan · 2019 · Scientific Reports
12. Induced oscillations and the distributed cortical sources during the Wisconsin card sorting test performance in schizophrenic patients: new clues to neural connectivity
    J.A. González-Hernández, I Cedeño, C. Pita-Alcorta, L. Galán, E Aubert, Pedro Figueredo-Rodríguez · 2003 · International Journal of Psychophysiology
13. Stochastic dynamic causal modeling of working memory connections in cocaine dependence
    Liangsuo Ma, Joel L. Steinberg, Khader M. Hasan, Ponnada A. Narayana, Larry A. Kramer, Frederick Gerard Moeller · 2012 · Human Brain Mapping
14. Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability
    Ingo Vernaleken, Majken Klomp, Olaf Moeller, Mardjan Raptis, Arne Nagels, Frank Rösch, Wolfgang Michael Schaefer, Paul D. Cumming, Gerhard Gründer · 2012 · The International Journal of Neuropsychopharmacology
15. Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical Trials
    Se Eun Jang, Lifeng Qiu, Ling Ling Chan, Eng‐King Tan, Li Zeng · 2020 · Frontiers in Neuroscience
16. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.
    D. Erritzoe, P. Talbot, W. Frankle, A. Abi-Dargham · 2003 · Neuroimaging clinics of North America
17. COMT and ANKK1 gene–gene interaction modulates contextual updating of mental representations
    Manuel García-García, Francisco Barceló, Imma C. Clemente, Carles Escera · 2011 · NeuroImage
18. Using human brain imaging studies as a guide toward animal models of schizophrenia
    Scott S. Bolkan, Fernanda Carvalho Poyraz, Christoph Kellendonk · 2015 · Neuroscience
19. Neonatal medial prefrontal cortex lesion enhances the sensitivity of the mesoaccumbal dopamine system
    Mustapha Bennay, Manuela Gernert, Kerstin Schwabe, Thomas Enkel, Michael Koch · 2004 · European Journal of Neuroscience
20. Isolation rearing or methamphetamine traumatisation induce a “dysconnection” of prefrontal efferents in gerbils: implications for schizophrenia
    Francesco Bagorda, Gertraud Teuchert, Konrad Lehmann · 2005 · Journal of Neural Transmission
21. Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion
    U.S Hess, S.P Whalen, Lorena Sandoval, GARY S. LYNCH, Christine M. Gall · 2003 · Neuroscience
22. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine d1/5 receptors in the prefrontal cortex?
    Ruben Isacson, Björn Kull, Claes Wahlestedt, Peter Salmi · 2004 · Neuroscience
23. Interactions between glutamate, dopamine, and the neuronal signature of response inhibition in the human striatum
    Robert C. Lorenz, Tobias Gleich, Ralph Buchert, Florian Schlagenhauf, Simone Kühn, Jürgen Gallinat · 2015 · Human Brain Mapping
24. Frontal glutamate and reward processing in adolescence and adulthood
    Tobias Gleich, Robert C. Lorenz, Lydia Pöhland, Diana Raufelder, Lorenz Deserno, Anne Beck, Andreas Heinz, Simone Kühn, Jürgen Gallinat · 2014 · Brain Structure and Function
25. A genetic locus in 7p12.2 associated with treatment resistant schizophrenia
    Jiang Li, Herbert Y. Meltzer · 2014 · Schizophrenia Research
26. Striatal development involves a switch in gene expression networks, followed by a myelination event: Implications for neuropsychiatric disease
    Gabriela Novak, Theresa Fan, Brian F. O’Dowd, Susan R. George · 2012 · Synapse
27. Australian guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis: report from the AACB Sweat Testing Working Party.
    John Coakley, Sue Scott, James C.G. Doery, Ronda Greaves, Peter Talsma, Elaine Whitham, Janet Winship · 2006 · PubMed
28. Detection of human salivary stress biomarkers using an easy-to-use array sensor based on fluorescent organic molecules
    Rossella Santonocito, Alessia Cavallaro, Andrea Pappalardo, Roberta Puglisi, Angela Marano, Manuela Andolina, Nunzio Tuccitto, Giuseppe Trusso Sfrazzetto · 2024 · Biosensors and Bioelectronics
29. unc5c haploinsufficient phenotype: striking similarities with the dcc haploinsufficiency model
    Meagan L. Auger, Ewoud R. E. Schmidt, C. Manitt, Gregory Dal-Bo, R. Pasterkamp, C. Flores · 2013 · European Journal of Neuroscience
30. Frontostriatal systems comprising connections between ventral medial prefrontal cortex and nucleus accumbens subregions differentially regulate motor impulse control in rats
    Malte Feja, Michael Koch · 2014 · Psychopharmacology
31. Developmentally induced imbalance of dopaminergic fibre densities in limbic brain regions of gerbils ( Meriones unguiculatus )
    Andrea Busche, Dierk Polascheck, Jörg Lesting, Joerg Neddens, Gertraud Teuchert · 2004 · Journal of Neural Transmission
32. Impaired Hierarchical Control Within the Lateral Prefrontal Cortex in Schizophrenia
    Guillaume Barbalat, Valérian Chambon, Philippe Domenech, Chrystèle Ody, Étienne Koechlin, Nicolás Franck, Chlöé Farrer · 2011 · Biological Psychiatry
33. Effects of High-Frequency rTMS on Negative Symptoms and Cognitive Function in Hospitalized Patients With Chronic Schizophrenia: A Double-Blind, Sham-Controlled Pilot Trial
    Na Wen, Lei Chen, Xuemeng Miao, Min Zhang, Yaoyao Zhang, Jie Liu, Yao Qun Xu, Siyu Tong, Wei Tang, Mengpu Wang et al. · 2021 · Frontiers in Psychiatry
34. Hyperresponsivity and impaired prefrontal control of the mesolimbic reward system in schizophrenia
    Anja Richter, Aleksandra Petrovic, Esther Kristina Diekhof, Sarah Trost, Sarah Wolter, Oliver Gruber · 2015 · Journal of Psychiatric Research
35. Stroop interference effect in schizophrenic patients: An electrophysiological approach
    Jaana Markela-Lerenc, Christian Schmidt-Kraepelin, Daniela Roesch-Ely, Christoph Mundt, Matthias Weisbrod, Stefan Kaiser · 2008 · International Journal of Psychophysiology
36. Voluntary wheel running ameliorates symptoms of MK-801-induced schizophrenia in mice
    Tae-Woon Kim, Hyun‐Sik Kang, Joon-Ki Park, Sam‐Jun Lee, Sang-Bin Baek, Chang‐Ju Kim · 2014 · Molecular Medicine Reports
37. Task-evoked substantia nigra hyperactivity associated with prefrontal hypofunction, prefrontonigral disconnectivity and nigrostriatal connectivity predicting psychosis severity in medication naïve first episode schizophrenia
    Jong H. Yoon, Andrew J. Westphal, Michael J. Minzenberg, T. Niendam, J. Ragland, T. Lesh, Marjorie Solomon, Cameron S. Carter · 2014 · Schizophrenia Research
38. Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processing
    Anni Richter, Sylvia Richter, Adriana Barman, Joram Soch, Marieke Klein, Anne Assmann, Catherine Libeau, Gusalija Behnisch, Torsten Wüstenberg, Constanze I. Seidenbecher et al. · 2013 · Frontiers in Human Neuroscience
39. Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia
    Ashley J. Skilleter, Cynthia Shannon Weickert, Ans Vercammen, Rhoshel Lenroot, Thomas Wesley Weickert · 2014 · Psychological Medicine
40. The role of modern imaging modalities on deep brain stimulation targeting for mental illness
    Mark F. Sedrak, Alessandra Augusta Gorgulho, Antonio F. De Salles, A. Frew, E.J. Behnke, Warren Ishida, Tony Klochkov, Dennis R. Malkasian · 2008 · Acta neurochirurgica. Supplementum
41. Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-Sensitive Magnetic Resonance Imaging and [18F]-DOPA Positron Emission Tomography Study
    Luke James Vano, Robert Ali McCutcheon, Grazia Rutigliano, Stephen John Kaar, Valeria Finelli, Giovanna Nordio, George Wellby, Jan Sedlacik, Ben K. Statton, Eugenii A. Rabiner et al. · 2024 · Biological Psychiatry
42. COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls
    Alan E. Ceaser, John G. Csernansky, Deanna M. Barch · 2012 · Cognitive Neuropsychiatry
43. The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal 18F-DOPA PET and voxel-based morphometry study
    Enrico D’Ambrosio, Sameer Jauhar, Seoyoung Kim, Mattia Veronese, Maria Rogdaki, Fiona Pepper, Ilaria Bonoldi, Vasileia Kotoula, Matthew J. Kempton, Federico Turkheimer et al. · 2019 · Molecular Psychiatry
44. Neurochemical dysfunction in treated and nontreated schizophrenia – a retrospective analysis of in vivo imaging studies
    S. Nikolaus, H. Hautzel, H. Müller · 2014 · Reviews in the Neurosciences
45. Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli
    Thorsten Kienast, Thomas Siessmeier, Jana Wrase, Dieter F. Braus, Michael N. Smolka, Hans Georg Buchholz, Michael A. Rapp, Mathias Schreckenberger, Frank Rösch, Paul D. Cumming et al. · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
46. Fluphenazine (oral) versus placebo for schizophrenia
    Hosam E. Matar, Muhammad Qutayba Almerie, Stephanie J Sampson · 2013 · Cochrane Database of Systematic Reviews
47. Reinforcement Learning Performance and Risk for Psychosis in Youth
    James A. Waltz, Caroline Demro, Jason Eric Schiffman, Elizabeth Thompson, Emily R. Kline, Gloria M. Reeves, Ziye Xu, James M. Gold · 2015 · The Journal of Nervous and Mental Disease
48. Learning to be inflexible: Enhanced attentional biases in Parkinson's disease
    Sean James Fallon, Adam Hampshire, Roger A. Barker, Adrian Mark Owen · 2016 · Cortex
49. Computational psychopharmacology: a translational and pragmatic approach
    Robbins, Trevor W., Cardinal, Rudolf N. · 2019 · Psychopharmacology
50. Smartphone-Based Dopamine Detection by Fluorescent Supramolecular Sensor
    Rossella Santonocito, Nunzio Tuccitto, Andrea Pappalardo, Giuseppe Trusso Sfrazzetto · 2022 · Molecules
51. Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects
    Ingo Vernaleken, Yoshitaka Kumakura, Hans‐Georg Buchholz, Thomas Siessmeier, R.-D Hilgers, Peter Bartenstein, Paul D. Cumming, Gerhard Gründer · 2008 · NeuroImage
52. Decreased CaMKII and PKC activities in specific brain regions are associated with cognitive impairment in neonatal ventral hippocampus-lesioned rats
    Yasushi Yabuki, Osamu Nakagawasai, Shigeki Moriguchi, Norifumi Shioda, Hiroshi Onogi, Koichi Tan–No, T. Tadano, Kohji Fukunaga · 2013 · Neuroscience
53. Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders.
    M. Slifstein, A. Abi-Dargham · 2017 · Seminars in nuclear medicine
54. Meta-Analysis of Transcriptomic Data of Dorsolateral Prefrontal Cortex and of Peripheral Blood Mononuclear Cells Identifies Altered Pathways in Schizophrenia
    Maria Cristina Petralia, Rosella Ciurleo, Andrea Saraceno, Manuela Pennisi, Maria Sofia Basile, Paolo Fagone, Placido Bramanti, Ferdinando Nicoletti, Eugenio Cavalli · 2020 · Genes
55. Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia
    Tejas S. Bhojraj, Vaibhav A. Diwadkar, John A. Sweeney, Konasale M. R. Prasad, Shaun M. Eack, Debra M. Montrose, Matcheri S. Keshavan · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
56. Striatal cerebral blood flow, executive functioning, and fronto-striatal functional connectivity in clinical high risk for psychosis
    Daniela Hubl, Frauke Schultze‐Lutter, Martinus Hauf, Thomas Dierks, Andrea Federspiel, Michael Kaess, Chantal Michel, BENNO GRAF SCHIMMELMANN, Jochen Kindler · 2018 · Schizophrenia Research
57. <scp>Neanderthal‐derived</scp> genetic variation in living humans relates to schizophrenia diagnosis, to psychotic symptom severity, and to dopamine synthesis
    Gregory, Michael D., Eisenberg, Daniel P., Hamborg, Madeline, Kippenhan, J. Shane, Kohn, Philip, Kolachana, Bhaskar, Dickinson, Dwight, Berman, Karen F. · 2021 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
58. Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidence.
    M. Bauer, N. Praschak-rieder, S. Kasper, M. Willeit · 2012 · Current pharmaceutical design
59. Effects of aripiprazole and haloperidol on neural activation during the n-back in healthy individuals: A functional MRI study
    Alexiοs Arvanitis, Antje A. T. S. Reinders, Rowena Handley, Tiago Reis Marques, Heather Taylor, Owen O’Daly, Grant McQueen, Kathryn Hubbard, Valeria Mondelli, Carmine Maria Pariante et al. · 2015 · Schizophrenia Research
60. Automated Data Quality Control in FDOPA brain PET Imaging using Deep Learning
    Antonella D. Pontoriero, Giovanna Nordio, Rubaida Easmin, Alessio Giacomel, Barbara Santangelo, Sameer Jauhar, Ilaria Bonoldi, Maria Rogdaki, Federico Turkheimer, Oliver David Howes et al. · 2021 · Computer Methods and Programs in Biomedicine
61. Resilience to amphetamine in mouse models of netrin-1 haploinsufficiency: role of mesocortical dopamine
    Matthew Pokinko, Luc Moquin, Angélica Torres‐Berrío, Alain P. Gratton, Cecilia Flores · 2015 · Psychopharmacology
62. Gene–environment interaction on cognition: A twin study of childhood maltreatment and COMT variability
    Ximena Goldberg, Mar Fatjó‐Vilas, Silvia Alemany, Igor Nenadić, Cristòbal Gastó, Lourdes Fañanás · 2013 · Journal of Psychiatric Research
63. Altered fronto–limbic activity in children and adolescents with familial high risk for schizophrenia
    Sarah J. Hart, Joshua Bizzell, Mary Agnes B. McMahon, Hongbin Gu, Diana O. Perkins, Ayşenil Belger · 2013 · Psychiatry Research Neuroimaging
64. Gene–gene Interaction Analyses Between NMDA Receptor Subunit and Dopamine Receptor Gene Variants and Clozapine Response
    Rudi Hwang, Renan Pedra de Souza, Arun Kumar Tiwari, Clement C.H. Zai, Daniel J. Müller, Steven G. Potkin, Jeffrey Alan Lieberman, Herbert Y Meltze, James L. Kennedy · 2011 · Pharmacogenomics
65. Common Variation in the DOPA Decarboxylase (DDC) Gene and Human Striatal DDC Activity In Vivo
    Daniel Paul Eisenberg, Philip D. Kohn, Catherine E. Hegarty, Angela M. Ianni, Bhaskar S. Kolachana, Michael D. Gregory, Joseph C. Masdeu, Karen Faith Berman · 2016 · Neuropsychopharmacology
66. Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [18F]DOPA and [11C]raclopride PET study in first-episode psychosis
    Seoyoung Kim, Sang Ho Shin, Barbara Santangelo, Mattia Veronese, Seung Kwan Kang, Jae Sung Lee, Gi Jeong Cheon, Woojoo Lee, Jun Soo Kwon, Oliver David Howes et al. · 2020 · Molecular Psychiatry
67. No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder
    Dennis Hernaus, Dina Collip, Zuzana Kasanova, Oliver Winz, Alexander Heinzel, Thérèse van Amelsvoort, Siamak Mohammadkhani Shali, Jan Booij, Rong Yu, Markus Piel et al. · 2015 · Translational Psychiatry
68. A Quantitative System Pharmacology Computer Model for Cognitive Deficits in Schizophrenia
    Hugo Geerts, P Roberts, Äthan Spiros · 2013 · CPT Pharmacometrics & Systems Pharmacology
69. Prenatal and perinatal risk factors of schizophrenia
    Giampiero Meli, Birgit Öttl, Angela Paladini, Luigi Cataldi · 2012 · The Journal of Maternal-Fetal & Neonatal Medicine
70. Intrinsic Connectivity of the Globus Pallidus: An Uncharted Marker of Functional Prognosis in People With First-Episode Schizophrenia
    Goda Tarcijonas, Will Foran, Gretchen L. Haas, Beatríz Luna, Deepak K. Sarpal · 2019 · Schizophrenia Bulletin
71. How genes make up your mind: Individual biological differences and value-based decisions
    Thomas Zoëga Ramsøy, Martin Skov · 2010 · Journal of Economic Psychology
72. Early amygdala damage disrupts performance on medial prefrontal cortex-related tasks but spares spatial learning and memory in the rat
    Leontien Diergaarde, Mirjam A. F. M. Gerrits, Judith Brouwers, Jan M. van Ree · 2004 · Neuroscience
73. Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophrenia
    Alexandra Ioppi Zugno, Felipe Damázio Pacheco, Josiane Budni, Mariana Bittencourt de Oliveira, Lara Canever, Alexandra S. Heylmann, Patrícia Gomes Wessler, Flávia da Rosa Silveira, Gustavo Antunes Mastella, Cinara Ludwig Gonçalves et al. · 2015 · Metabolic Brain Disease
74. Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia
    M. Reid, N. Kraguljac, K. B. Avsar, D. White, J. den Hollander, A. Lahti · 2013 · Schizophrenia Research
75. The Relationship Between Abnormal Resting-State Functional Connectivity of the Left Superior Frontal Gyrus and Cognitive Impairments in Youth-Onset Drug-Naïve Schizophrenia
    Xiaolei Qiu, Shuiping Lu, Min Zhou, Wei Yan, Jinglun Du, Aoshuang Zhang, Shiping Xie, Rongrong Zhang · 2021 · Frontiers in Psychiatry
76. Rapid dopaminergic and GABAergic modulation of calcium and voltage transients in dendrites of prefrontal cortex pyramidal neurons
    Wen‐Liang Zhou, Srdjan D. Antic · 2012 · The Journal of Physiology
77. Epigenetic reprogramming of cortical neurons through alteration of dopaminergic circuits
    Karen Brami‐Cherrier, Andrea Anzalone, M Ramos, Ignasi Forné, Fabio M. Macciardi, Axel Imhof, Emiliana Borrelli · 2014 · Molecular Psychiatry
78. Breakdown of the striatal-default mode network loop in schizophrenia.
    Xiangpeng Wang, Feng-hua Li, Han-feng Zheng, Wei-hong Wang, Wenwen Zhang, Zhao-yuan Liu, Yu-Jing Sun, R. Chan, An-Tao Chen · 2015 · Schizophrenia Research
79. Brain volumetric alterations accompanied with loss of striatal medium-sized spiny neurons and cortical parvalbumin expressing interneurons in Brd1+/− mice
    Per Qvist, Simon Fristed Eskildsen, Brian Hansen, Mohammad Baragji, Steffen Ringgaard, Jolien Roovers, Veerle Paternoster, Simon Mølgaard, Thomas J. Corydon, Hans Stødkilde‐Jørgensen et al. · 2018 · Scientific Reports
80. The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging Study
    Robert Ali McCutcheon, Sameer Jauhar, Fiona Pepper, Matthew M. Nour, Maria Rogdaki, Mattia Veronese, Federico Turkheimer, Alice Egerton, Philip K. McGuire, Mitul Ashok Mehta et al. · 2020 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
81. Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor
    Emilio Fernández‐Espejo, Beatriz Galán-Rodríguez · 2004 · Psychopharmacology
82. Interactive memory systems and category learning in schizophrenia
    Szabolcs Kéri · 2007 · Neuroscience & Biobehavioral Reviews
83. A Classification of Sociomedical Health Indicators: Perspectives for Health Administrators and Health Planners
    Athilia E. Siegmann · 1976 · International Journal of Health Services
84. Spontaneous Brain Activity Alterations in First-Episode Psychosis: A Meta-analysis of Functional Magnetic Resonance Imaging Studies
    Giulia Cattarinussi, David Antonio Grimaldi, Fabio Sambataro · 2023 · Schizophrenia Bulletin
85. Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis
    Ilona Klejbor, Aaron J. Kucinski, Scott R. Wersinger, Thomas D. Corso, Jan Henryk Spodnik, J Dziewíatkowski, Janusz Moryś, Renae A. Hesse, Kenner C. Rice, Robert S. Miletich et al. · 2009 · Schizophrenia Research
86. Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
    Laura E. Chavez-Noriega, Michael J. Marino, Hervé Schaffhauser, Una C. Campbell, Peter Jeffrey Conn · 2005 · Current Neuropharmacology
87. Structural abnormalities of the right inferior colliculus in schizophrenia
    Do-Hyung Kang, Ki Won Kwon, Bon-Mi Gu, Jung‐Seok Choi, Joon Hwan Jang, Jun Soo Kwon · 2008 · Psychiatry Research Neuroimaging
88. Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease
    Gerard W. O’Keeffe, Shane Vincent Hegarty, Aideen M. Sullivan · 2017 · Neuronal Signaling
89. Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions
    D. Eisenberg, L. Yankowitz, Angela M. Ianni, D. Rubinstein, Philip Kohn, Catherine E. Hegarty, Michael D. Gregory, J. Apud, K. Berman · 2017 · Neuropsychopharmacology
90. Assessment of the acquisition of executive function during the transition from adolescence to adulthood in male and female mice
    Ryan M. Shepard, Emily Beckett, Laurence D. Coutellier · 2017 · Developmental Cognitive Neuroscience
91. The influence of dopamine‐related genes on perceptual stability
    Katharina Schmack, Maria Sekutowicz, Hannes Rössler, Eva J. Brandl, Daniel J. Müller, Philipp Sterzer · 2013 · European Journal of Neuroscience
92. Quantitative mass spectrometry reveals changes in SNAP-25 isoforms in schizophrenia
    Vilte Barakauskas, Annie Moradian, Alasdair M. Barr, Clare L. Beasley, Gorazd B. Rosoklija, J. John Mann, Boro Ilievski, Aleksandar Stankov, Andrew J. Dwork, Peter Falkai et al. · 2016 · Schizophrenia Research
93. Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra
    Kirsten E. Schoonover, Lesley A. McCollum, R. Roberts · 2017 · Neuropsychopharmacology
94. Self‐Representation in Nervous Systems
    Patricia Smith Churchland · 2003 · Annals of the New York Academy of Sciences
95. Preclinical effects of conventional and atypical antipsychotic drugs: defining the mechanisms of action
    T. Svensson · 2003 · Clinical Neuroscience Research
96. Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivo
    Leonardo Sportelli, Daniel Paul Eisenberg, Roberta Passiatore, Enrico D’Ambrosio, Linda Antonella Antonucci, Jasmin S. Bettina, Qiang Chen, Aaron L. Goldman, Michael D. Gregory, Kira Griffiths et al. · 2024 · Nature Communications
97. Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats
    John G. Howland, Darren K. Hannesson, Anthony G. Phillips · 2004 · European Journal of Neuroscience
98. Neuroimaging Intermediate Phenotypes of Executive Control Dysfunction in Schizophrenia
    Grant Sutcliffe, Anais Harneit, Heike Tost, Andreas Meyer‐Lindenberg · 2016 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
99. Differential Associations between Cortical Thickness and Striatal Dopamine in Treatment-Naïve Adults with ADHD vs. Healthy Controls
    M. Cherkasova, Nazlie Faridi, K. Casey, K. Larcher, G. O'Driscoll, L. Hechtman, R. Joober, G. Baker, J. Palmer, Alan C. Evans et al. · 2017 · Frontiers in Human Neuroscience
100. Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [18F]DOPA PET and fMRI study
     Seoyoung Kim, Wi Hoon Jung, Oliver David Howes, Mattia Veronese, Federico Turkheimer, Yun‐Sang Lee, Jae Sung Lee, Euitae Kim, Jun Soo Kwon · 2018 · Psychological Medicine